San Diego, CA, United States of America

Matthew L Del Bel

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Matthew L. Del Bel

Introduction

Matthew L. Del Bel is an influential inventor based in San Diego, California, known for his contributions to the pharmaceutical field. With an impressive portfolio that includes two patents, Del Bel's work demonstrates his commitment to advancing medical science and technology.

Latest Patents

Among his noteworthy inventions are the Azalactam compounds as HPK1 inhibitors. This invention focuses on compounds represented by a specific general Formula I, which holds potential in the treatment of various diseases. Such innovations reflect Del Bel's dedication to creating solutions that could significantly impact health care and therapeutic development.

Career Highlights

Matthew L. Del Bel's career has been marked by his association with Pfizer Corporation, a well-respected player in the pharmaceutical industry. His role at Pfizer allows him to be at the forefront of research and development, contributing to the creation of novel therapies and improving patient outcomes.

Collaborations

Throughout his career, Del Bel has collaborated with esteemed colleagues, including Rebecca Anne Gallego and Sajiv Krishnan Nair. These partnerships highlight his ability to work effectively in a team setting and leverage the strengths of others in the pursuit of innovative solutions.

Conclusion

Matthew L. Del Bel stands out as a remarkable inventor whose work in Azalactam compounds showcases his significant contributions to the medical field. His ongoing efforts at Pfizer, combined with his collaborations, continue to inspire advancements in pharmaceutical research. As he furthers his journey of innovation, the impact of his inventions will undoubtedly resonate within the industry and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…